Showing 28–32 of 32 results
Recurrent Abortion Profile I (Genetic Origin) is a specialized diagnostic panel designed to identify genetic and protein-based causes of recurrent pregnancy loss.
Sample Type : Whole Blood+Plasma
Methodology : NA
TAT : “7 Days(IH), APCR (OT)-14 days”
The **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine.
The **SPINAL MUSCULAR ATROPHY (SMA) Test** is a cutting-edge genetic screening tool designed to detect mutations in the **SMN1 gene**, the primary cause of SMA, a severe neuromuscular disorder. This highly accurate test enables **early diagnosis**, allowing for timely medical intervention and personalized treatment plans. It is **non-invasive**, requiring only a simple blood or saliva sample, and delivers **fast, reliable results**. Ideal for **newborn screening, carrier detection, and prenatal testing**, it empowers individuals and families with crucial genetic insights. With advanced technology ensuring **high sensitivity and specificity**, this test is a must-have for proactive healthcare and informed decision-making.
Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.
The Y Chromosome Microdeletion (YCMD) Blood Test is a specialized genetic screening designed exclusively for males to detect microdeletions in the Y chromosome, a key factor in male infertility. This test identifies deletions in the AZF (Azoospermia Factor) regions, which are crucial for sperm production.